Daré Bioscience (DARE) Stock Statistics & Valuation Metrics

Daré Bioscience has a market cap or net worth of $27.35M. The enterprise value is $18.38M.

Daré Bioscience has 8,850,386 shares outstanding. The number of shares has decreased by -2.65% in one year.

Daré Bioscience’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -2.25%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Daré Bioscience had revenue of 9.78K and earned -4.05M in profits. Earnings per share was -0.48.

In the last 12 months, operating cash flow was -12.99M and capital expenditures -445.15K, giving a free cash flow of -13.43M billion.

Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Daré Bioscience upcoming earnings date is Aug 7, 2025, TBA (Confirmed).

Daré Bioscience as a current ratio of 0.85, with Debt / Equity ratio of -37.36%

In the past 12 months, Daré Bioscience has paid 0.00 in taxes.

Daré Bioscience EV to EBITDA ratio is -3.42, with an EV/FCF ratio of 2.51.

Daré Bioscience has $10.33M in cash and marketable securities with $3.57M in debt, giving a net cash position of -$6.76M billion.

Gross margin is -0.25%, with operating margin of -239692.20%, and net profit margin of -41430.90%.

The average price target for Daré Bioscience is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy